Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Ya Tuo
Introduction
Ya Tuo is a notable inventor based in Beijing, China. He has made significant strides in the field of cancer treatment through his innovative research and development. His work focuses on the use of Icaritin, a compound that shows promise in improving patient outcomes while minimizing adverse effects.
Latest Patents
Ya Tuo holds a patent for the "Use of Icaritin for the preparation of composition for treating cancer." This invention outlines a method for administering Icaritin orally to patients over a continuous 28-day dosing schedule. The recommended dosage ranges from 400 to 1800 mg daily, with the goal of enhancing treatment efficacy and reducing side effects for patients undergoing cancer therapy.
Career Highlights
Ya Tuo is affiliated with Beijing Shenogen Pharma Group Ltd., where he contributes to the advancement of pharmaceutical innovations. His dedication to improving cancer treatment options has positioned him as a key figure in the research community.
Collaborations
Ya Tuo collaborates with esteemed colleagues, including Kun Meng and Hongxia Ding, who share his commitment to advancing medical science and improving patient care.
Conclusion
Ya Tuo's contributions to cancer treatment through his patent on Icaritin exemplify the impact of innovative research in medicine. His work continues to inspire advancements in therapeutic approaches for cancer patients.